Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ferdinando D'Amico and Laurent Peyrin-Biroulet.
Ferdinando D'Amico
Connection Strength
6.077
Laurent Peyrin-Biroulet
  1. Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience. J Clin Med. 2020 Aug 20; 9(9).
    View in: PubMed
    Score: 0.898
  2. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock. Clin Gastroenterol Hepatol. 2020 11; 18(12):2689-2700.
    View in: PubMed
    Score: 0.896
  3. Reply. Clin Gastroenterol Hepatol. 2020 12; 18(13):3055.
    View in: PubMed
    Score: 0.888
  4. Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clin Gastroenterol Hepatol. 2020 07; 18(8):1663-1672.
    View in: PubMed
    Score: 0.876
  5. SARS-CoV-2 vaccination in IBD: more pros than cons. Nat Rev Gastroenterol Hepatol. 2021 04; 18(4):211-213.
    View in: PubMed
    Score: 0.234
  6. Reply. Gastroenterology. 2021 05; 160(6):2223-2224.
    View in: PubMed
    Score: 0.232
  7. Will COVID-19 Infection be Less Severe in Ulcerative Colitis Than in Crohn's Patients, Due to a Lower Rate of Smokers? J Crohns Colitis. 2020 Nov 07; 14(11):1648.
    View in: PubMed
    Score: 0.228
  8. SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience. Nat Rev Gastroenterol Hepatol. 2020 08; 17(8):507-516.
    View in: PubMed
    Score: 0.222
  9. Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic. J Clin Med. 2020 May 19; 9(5).
    View in: PubMed
    Score: 0.221
  10. Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey. Lancet Gastroenterol Hepatol. 2020 07; 5(7):631-632.
    View in: PubMed
    Score: 0.220
  11. Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization. Gastroenterology. 2020 Jul; 159(1):14-19.e3.
    View in: PubMed
    Score: 0.220
  12. Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy. Gastroenterology. 2020 Jun; 158(8):2302-2304.
    View in: PubMed
    Score: 0.219
  13. Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience. Therap Adv Gastroenterol. 2019; 12:1756284819848631.
    View in: PubMed
    Score: 0.206
  14. Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing. Immunotherapy. 2019 05; 11(7):565-575.
    View in: PubMed
    Score: 0.203
  15. Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis. Inflamm Bowel Dis. 2018 09 15; 24(10):2106-2112.
    View in: PubMed
    Score: 0.196
  16. IBD goes home: from telemedicine to self-administered advanced therapies. Expert Opin Biol Ther. 2022 01; 22(1):17-29.
    View in: PubMed
    Score: 0.060
  17. Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study. J Clin Med. 2020 Oct 31; 9(11).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.